Steven Johnson SyndromeMonika 6-6-2011

Embed Size (px)

Citation preview

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    1/20

    MEDICAL

    CASE PRESENTATION ON

    STEVEN JOHNSON SYNDROM

    BY MONICA SWAMIG.N.M.2nd year

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    2/20

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    3/20

    Anatomy of Skin

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    4/20

    Person with Steven Johnson Syndrome

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    5/20

    Definition

    Steven Johnson Syndrome is a fatal skin

    disorder and the most severe form of

    erythematic multiform:- The mortality rate from (SJS) approaches

    (30%) .

    Antibiotic ant seizure agents but zones

    and sulfonamide are the most frequent

    medications implicated in (SJS).

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    6/20

    Introduction

    SJS disease are mucocutaneous reactions

    that constitute a spectrum of reactions, with

    SJS being the most severe.

    Mortality Rate :- The mortality rate from SJSare trigger by reaction of Medications,

    Antibiotics epically Sulfonamides, Ant

    seizure agents .Note: - Sulfonamides are the most frequent

    medications implicated.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    7/20

    Clinical Manifestations

    SJS is Characterized by conjunctiva burning

    or itching.

    Coetaneous tenderness, fever, cough, sore-throat,headache,extrememalais and myalgias

    (aches& pain).

    These signs are followed by a rapid onset

    of erytemia involving much of skin surfaceand mucous membrane including the oral

    mucosa, and conjunctiva any genitalia

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    8/20

    Incidence Increase in

    a. The incidence is increased in older peoplebecause of their use of many medications.

    b. People wit (HIV) particularly those with

    acquired immunodeficiencysymdrome(AIDS) and other who areimmunocompromised are at the higher riskfor (SJS).

    Risk Associated with:- Sulfonamide in (HIV)positive individuals may approach 1 case per1000 odometal 2000.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    9/20

    Diagnostic Finding

    1. Histologic studies of frozen skin cells

    from a fresh lession and cytodiagnosis

    collection of celluar material from a freshy

    denuded area are performed.

    2. A genetic Predispostion to erythemia

    multiform has been suggested but not

    confirmed for all case.

    Condiction Effecing :- all ages both genders.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    10/20

    Nursing Process

    1. A careful inspection of skin is made

    including its appearance and the extend

    of involvements.

    2. Pt. vital sign monitor and special attention

    is given to the rhythm, and cough.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    11/20

    Risk Factor In My Patient

    Reactions of medicines.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    12/20

    Clinical Manifestation in my Patitent

    Conjunctival Burning.

    Cutaneous Tenderness.

    Fever.Pain in Hole Body.

    Bleeding from lips.

    Skin Colour is gone Black.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    13/20

    PathoPhysiology

    It is Unknown.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    14/20

    Complications

    Sepsis and Kerato conjuctivitis are

    Complications of (SJS).

    Un recognized and untreated sepsis can be life

    threatening.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    15/20

    Progress During Conversation

    21.4.011- I took history ofPt. when she was

    telling me how she met with this disease her

    words was not clear.

    22.4.011 I went to pt. room she was feeling

    well the words she was saying was some

    correct her lips was bleeding.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    16/20

    Nursing Management

    Medical Management

    The goals of treatment include control of fluidand electrolyte balance, prevention of sepsis and

    prevention of Opthalmic complications.Supporative care is the main treatment.

    All nonessential medications are discontinuedimmediately.

    If possible pt. is treated in a regional burn centre,because aggressive treatment similar to that forsevere burn is required.

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    17/20

    Nursing Care Plan

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    18/20

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    19/20

  • 8/6/2019 Steven Johnson SyndromeMonika 6-6-2011

    20/20